Cadrenal Therapeutics, Inc. (CVKD)

Cadrenal Therapeutics Statistics

Total Valuation

CVKD has a market cap or net worth of $17.15 million. The enterprise value is $13.31 million.

Market Cap	17.15M
Enterprise Value	13.31M

Important Dates

The last earnings date was Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

CVKD has 2.08 million shares outstanding. The number of shares has increased by 47.19% in one year.

Current Share Class	2.08M
Shares Outstanding	2.08M
Shares Change (YoY)	+47.19%
Shares Change (QoQ)	+4.20%
Owned by Insiders (%)	25.59%
Owned by Institutions (%)	9.43%
Float	1.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.23
P/TBV Ratio	6.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.02

Current Ratio	3.02
Quick Ratio	2.86
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -468.03% and return on invested capital (ROIC) is -298.28%.

Return on Equity (ROE)	-468.03%
Return on Assets (ROA)	-209.23%
Return on Invested Capital (ROIC)	-298.28%
Return on Capital Employed (ROCE)	-536.56%
Revenue Per Employee	n/a
Profits Per Employee	-$3.60M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.56% in the last 52 weeks. The beta is 1.10, so CVKD's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	-45.56%
50-Day Moving Average	12.61
200-Day Moving Average	14.09
Relative Strength Index (RSI)	21.92
Average Volume (20 Days)	17,678

Short Selling Information

The latest short interest is 27,737, so 1.34% of the outstanding shares have been sold short.

Short Interest	27,737
Short Previous Month	28,386
Short % of Shares Out	1.34%
Short % of Float	1.80%
Short Ratio (days to cover)	1.33

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.67M
Pretax Income	-14.39M
Net Income	-14.39M
EBITDA	-14.67M
EBIT	-14.67M
Earnings Per Share (EPS)	-$8.19

Balance Sheet

The company has $3.86 million in cash and n/a in debt, giving a net cash position of $3.86 million or $1.86 per share.

Cash & Cash Equivalents	3.86M
Total Debt	n/a
Net Cash	3.86M
Net Cash Per Share	$1.86
Equity (Book Value)	2.73M
Book Value Per Share	1.33
Working Capital	2.73M

Cash Flow

In the last 12 months, operating cash flow was -$11.82 million and capital expenditures -$11,641, giving a free cash flow of -$11.83 million.

Operating Cash Flow	-11.82M
Capital Expenditures	-11,641
Free Cash Flow	-11.83M
FCF Per Share	-$5.70

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CVKD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-47.19%
Shareholder Yield	-47.19%
Earnings Yield	-83.80%
FCF Yield	-68.93%

Analyst Forecast

The average price target for CVKD is $32.00, which is 287.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.00
Price Target Difference	287.41%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-22.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 20, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Aug 20, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1